You are here: Home / Research / Research Disciplines / Non-Ruminant Nutrition Research

Non-Ruminant Nutrition Research

Non-Ruminant Nutrition Research

Dr. Scott Carter

Dr. Carter is an associate professor who teaches principles of nutrition, swine science, special problems in advance swine nutrition, and protein nutrition.  He was the associate editor of American Society of Animal Science from 2008-2010. Dr. Carter is an Ex- Officio board member of the Oklahoma Pork Council.  His research interests are in the impact of diet on nutrient excretion and gaseous emissions, effect of alternative feedstuffs on growth performance and carcass traits, effects of feed additives in on growth performance, and carcass traits.

Dr. Adel Pezeshki

Dr. Pezeshki’s research focuses on nutritional biochemistry of proteins and amino acids. In particular, he is interested in understanding the effect of individual amino acids and dietary proteins on health and growth development of young pigs and the physiological mechanisms by which they regulate energy balance and nutrients digestion, absorption and metabolism at cellular and whole-body levels. Further, he is interested in understanding the effect of other nutritional factors on proteins/amino acids digestion and absorption in the gut and their metabolism in various organs. Using young pigs for his research, the ultimate goal of Dr. Pezeshki’s research program is to develop novel strategies to improve the metabolic health and growth during postnatal life. Dr. Pezeshki’s group approaches the above aims by assessing various physiological parameters and mechanisms using variety of technologies and tools. Dr. Pezeshki’s dual purpose research contributes to swine and pediatrics nutrition and hence it benefits both agricultural and health care industries.

Dr. Glenn Zhang

Now with the use of medically important antibiotics being banned for growth promotion in livestock animals in the U.S., more effective alternatives to antibiotics are urgently needed to ensure animal health and productivity.  Dr. Zhang’s group is in pursuit of two different approaches to the development of novel antibiotic alternatives by employing a series of the state-of-the-art technologies in molecular immunology, functional genomics, metagenomics, and bioinformatics.  One approach is to modulate the synthesis of endogenous host defense peptides (HDPs) with the goal to develop HDP-inducing dietary compounds for disease control and prevention ("Modulating Innate Host Defense").  The second approach is to manipulate the structure and function of intestinal microbiota for optimal health and production efficiency.

Faculty

It's a Brand, It's a Tradition, It's You